Back to top

Biohaven enters into clinical supply agreement with Regeneron

Biohaven (BHVN) has entered into a clinical supply agreement with Regeneron Pharmaceuticals (REGN) to evaluate the combination of BHV-1530 and cemi...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Biohaven Ltd. (BHVN)

Regeneron Pharmaceuticals, Inc. (REGN)